certificate of analysis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-18. Numbers and descriptions here follow the published literature rather than marketing material.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small molecule | Studied as a REV-ERB agonist |
| Molecular formula | C20H24ClN3O4S | Reported for the neutral compound |
| Appearance | Off-white to pale yellow solid | Typical research-grade material |
| Solubility | Sparingly soluble in water | Soluble in solvents such as DMSO |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal alias |
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
== Sources == MCD peptide is a component of bumblebee (Megabombus pennsylvanicus) venom. In addition to MCD peptide, melittin and apamin have also been identified in this venom and are also described as voltage-dependent channel blockers. MCD peptide is also present in the venom of the honey bee Apis mellifera.
Abietic acid dermatitis Acid-induced Acrylic monomer dermatitis Adhesive dermatitis African blackwood dermatitis Airbag dermatitis (airbag burn) Alkali-induced Allergic Antifungal agent-induced Antimicrobial agent-induced Arsenic dermatitis Artificial nail-induced Axillary antiperspirant-induced Axillary deodorant-induced Baboon syndrome Black dermatographism Bleaching cream-induced Capsaisin-induced Chemical burn Chloracne Chrome dermatitis Clothing-induced Cobalt dermatitis Contact stomatitis (contact lichenoid reaction, lichenoid amalgam reaction, oral mucosal cinnamon reaction) Contact urticaria Corticosteroid-induced Cosmetic dermatitis Cosmetic intolerance syndrome Dentifrice-induced Dermatitis from metals and metal salts Dust-induced Epoxy resin dermatitis Ethylenediamine-induced Eye makeup-induced Fiberglass dermatitis Flower-induced Formaldehyde-induced Formaldehyde-releasing agent-induced Fragrance-induced Gold dermatitis Hair bleach-induced Hair dye-induced Hair lotion-induced Hair spray-induced Hair straightener-induced Hair tonic-induced Houseplant-induced Hydrocarbon-induced Irritant folliculitis Lacquer dermatitis (lacquer sensitivity) Lanolin-induced Lipstick-induced Local anesthetic-induced Makassar ebony dermatitis Marine plant-induced Mechanical irritant dermatitis Mercury dermatitis Mouthwash-induced Nail lacquer-induced Nail polish remover-induced Nickel dermatitis Occupation-induced p-Chloro-meta-xylenol-induced Paraben-induced Paraphenylenediamine dermatitis Permanent wave preparation-induced Phenothiazine drug-induced Photoallergic Photoirritant Plant derivative-induced Pollen-induced Polyester resin dermatitis Propylene glycol-induced Protein contact dermatitis Quaternium-15 hypersensitivity Reed dermatitis Rosewood dermatitis Rosin dermatitis Rubber dermatitis Seed-induced Shoe dermatitis Solvent-induced Sorbic acid-induced Subjective irritant contact dermatitis (sensory irritant contact dermatitis) Sunscreen-induced Systemic contact dermatitis Tear gas dermatitis Textile dermatitis Traumatic irritant contact dermatitis Tree-associated plant-induced Tree-induced Tulip fingers Urushiol-induced Vegetable-induced
=== Size and hands === A study investigating the relationship with digit ratio and found men with longer ring fingers than index fingers had longer penises, and it was the only significant predictor of both stretched and erect penis length. However, the common misconception that overall hand size predicts penis size has been widely discredited.
Sources: en.wikipedia.org
Primary myocardial infarction arises spontaneously from acute coronary pathology, such as coronary thrombus or dissection. Secondary myocardial infarction refers to coronary pathology exposed by supply-demand mismatch by some secondary cause. Procedure-related myocardial infarction refers to a complication of PCI or CABG wherein the stented artery or coronary graft spontaneously occludes within 30 days of the procedure.
In Australia, local soccer clubs, competitions and associations were mostly established independently and later affiliated with regional and states and territory bodies. A federated model of national, states and territories bodies developed since the first state body was established in New South Wales in 1882. Today, there is FA, the professional leagues, nine state and territory member federations and over 100 district, regional and local zones and associations.
=== Adverse effects specific to intravenous paracetamol === Intravenous paracetamol has consistently been shown to have hemodynamic effects, reducing systolic, diastolic, and mean arterial blood pressure. In a minority of cases, this side effect has been associated with cardiac arrest. Hypotension is hypothesized to occur due to the addition of mannitol in intravenous formulations of paracetamol, which is done to enhance solubility. Other side effects specific to IV paracetamol include pain at injection site.
Sources: en.wikipedia.org
=== Agriculture === The primary use of ammonium sulfate is as a fertilizer for alkaline soils. In the soil, the ammonium ion is released and forms a small amount of acid, lowering the pH balance of the soil, while contributing essential nitrogen for plant growth. One disadvantage to the use of ammonium sulfate is its low nitrogen content relative to ammonium nitrate or urea, which elevates transportation costs. It is also used as an agricultural spray adjuvant for water-soluble insecticides, herbicides, and fungicides. There, it functions to bind iron and calcium cations that are present in both well water and plant cells. It is particularly effective as an adjuvant for 2,4-D (amine), glyphosate, and glufosinate herbicides.
These increases are partially related to the COVID-19 pandemic, which continues to highlight the weaknesses of current food and health systems. It has contributed to food insecurity, increasing hunger worldwide; meanwhile, lower physical activity during lockdowns has contributed to increases in overweight and obesity. In 2020, experts estimated that by the end of the year, the pandemic could have double the number of people at risk of suffering acute hunger, around 130 million more undernourished people. Similarly, experts estimated that the prevalence of moderate and severe wasting could increase by 14% due to COVID-19; coupled with reductions in nutrition and health services coverage, this could result in over 128,000 additional deaths among children under 5 in 2020 alone. Although COVID-19 is less severe in children than in adults, the risk of severe disease increases with undernutrition. Other major causes of hunger include manmade conflicts, climate changes, and economic downturns.
=== EC 1.8.99 With other acceptors === EC 1.8.99.1: Now covered by EC 1.8.1.2, assimilatory sulfite reductase (NADPH) and EC 1.8.7.1, assimilatory sulfite reductase (ferredoxin) EC 1.8.99.2: adenylyl-sulfate reductase EC 1.8.99.3: an in vitro artifact of EC 1.8.1.22, dissimilatory sulfite reductase EC 1.8.99.4: Now EC 1.8.4.8, phosphoadenylyl-sulfate reductase (thioredoxin) EC 1.8.99.5: Now EC 1.8.1.22, dissimilatory sulfite reductase
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.
No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.
Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.